Pharma · Private company
Servier
Track this companyFree. Adds Servier to your Dealase workspace and tells you when its record changes.
Clinical trials87 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials8
- Ivosidenib as Post-HSCT Maintenance for AMLPHASE2 · RECRUITING · started Jan 16, 2026ClinicalTrials.gov NCT06707493 · fetched Nov 12, 2026
- ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade GliomasPHASE1 · RECRUITING · started Jul 15, 2025ClinicalTrials.gov NCT05609994 · fetched Nov 12, 2026
- CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)PHASE1 · RECRUITING · started May 1, 2023ClinicalTrials.gov NCT05581030 · fetched Nov 12, 2026
- Venetoclax Basket Trial for High Risk Hematologic MalignanciesPHASE1 · RECRUITING · started Mar 29, 2023ClinicalTrials.gov NCT05292664 · fetched Nov 12, 2026
- Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AMLPHASE2 · RECRUITING · started Mar 23, 2022ClinicalTrials.gov NCT05184842 · fetched Nov 12, 2026
- Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and LymphomaPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Mar 29, 2017ClinicalTrials.gov NCT03117751 · fetched Nov 12, 2026
- Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and AdolescentsPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 3, 2017ClinicalTrials.gov NCT03020030 · fetched Nov 12, 2026
- Pharmacokinetics of AGO178 in Participants With Liver ImpairmentPHASE1 · COMPLETED · started Feb 8, 2011ClinicalTrials.gov NCT01531309 · fetched Nov 12, 2026